Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales.
cohort study
type 1 diabetes
type 2 diabetes
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
05
08
2021
received:
21
06
2021
accepted:
14
08
2021
pubmed:
19
8
2021
medline:
15
12
2021
entrez:
18
8
2021
Statut:
ppublish
Résumé
To conduct an analysis to assess whether the completion of recommended diabetes care processes (glycated haemoglobin [HbA1c], creatinine, cholesterol, blood pressure, body mass index [BMI], smoking habit, urinary albumin, retinal and foot examinations) at least annually is associated with mortality. A cohort from the National Diabetes Audit of England and Wales comprising 179 105 people with type 1 and 1 397 790 people with type 2 diabetes, aged 17 to 99 years on January 1, 2009, diagnosed before January 1, 2009 and alive on April 1, 2013 was followed to December 31, 2019. Cox proportional hazards models adjusting for demographic characteristics, smoking, HbA1c, blood pressure, serum cholesterol, BMI, duration of diagnosis, estimated glomerular filtration rate, prior myocardial infarction, stroke, heart failure, respiratory disease and cancer, were used to investigate whether care processes recorded January 1, 2009 to March 31, 2010 were associated with subsequent mortality. Over a mean follow-up of 7.5 and 7.0 years there were 26 915 and 388 093 deaths in people with type 1 and type 2 diabetes, respectively. Completion of five or fewer, compared to eight, care processes (retinal screening not included as data were not reliable) had a mortality hazard ratio (HR) of 1.37 (95% confidence interval [CI] 1.28-1.46) in people with type 1 and 1.32 (95% CI 1.30-1.35) in people with type 2 diabetes. The HR was higher for respiratory disease deaths and lower in South Asian ethnic groups. People with diabetes who have fewer routine care processes have higher mortality. Further research is required into whether different approaches to care might improve outcomes for this high-risk group.
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2728-2740Subventions
Organisme : British Heart Foundation
ID : RE/18/6/34217
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854-865. https://doi.org/10.1016/S0140-6736(98)07037-8
Cholesterol Treatment Trialistsʼ (CTT) Collaborators, Mihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581-590. https://doi.org/10.1016/S0140-6736(12)60367-5
de Boer IH, Bangalore S, Benetos A, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273-1284. https://doi.org/10.2337/dci17-0026
National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management, NICE guideline (NG17). https://www.nice.org.uk/guidance/ng17. Accessed March 20, 2019.
National Institute for Health and Care Excellence. Type 2 diabetes in adults: management NICE guideline. https://www.nice.org.uk/guidance/ng28. Accessed August 16, 2019.
International Diabetes Federation. IDF Global Guideline for Type 2 Diabetes. https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes. Published 2017. Accessed March 25, 2019.
American Diabetes Association. 3. Comprehensive medical evaluation and assessment of comorbidities. Diabetes Care. 2017;40(suppl 1):S25-S32. https://doi.org/10.2337/dc17-S006
NHS Digital. Quality Outcomes Framework (QOF). 2020. https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/general-practice-data-hub/quality-outcomes-framework-qof. Accessed January 17, 2020.
Holman N, Knighton P, Wild SH, et al. Cohort profile: National Diabetes Audit for England and Wales. Diabet Med. 2021;38:e14616. https://doi.org/10.1111/dme.14616
NHS Digital. National Diabetes Audit - 2009-10, Audit analysis. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/national-diabetes-audit-2009-10-audit-analysis. Accessed August 5, 2021.
Office for National Statistics. Index of Multiple Deprivation (IMD) 2007. https://data.gov.uk/dataset/bdc1e1a5-aaf3-4f5a-9988-82a11e341eb8/index-of-multiple-deprivation-imd-2007. Accessed April 8, 2021.
Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254. https://doi.org/10.7326/0003-4819-145-4-200608150-00004
Breslow NE, Day NE. Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci Publ. 1987;82:1-406. http://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Statistical-Methods-In-Cancer-Research-Volume-II-The-Design-And-Analysis-Of-Cohort-Studies-1986. Accessed March 22, 2019.
Seidu S, Davies MJ, Farooqi A, Khunti K. Integrated primary care: is this the solution to the diabetes epidemic? Diabet Med. 2017;34(6):748-750. https://doi.org/10.1111/dme.13348
Wright AK, Kontopantelis E, Emsley R, et al. Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups. Diabetes Care. 2017;40(3):338-345. https://doi.org/10.2337/dc16-1616
Malik MO, Govan L, Petrie JR, et al. Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia. 2015;58(4):716-725. https://doi.org/10.1007/s00125-015-3492-0
Tillin T, Hughes AD, Mayet J, et al. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited)-a prospective population-based study. J Am Coll Cardiol. 2013;61(17):1777-1786. https://doi.org/10.1016/j.jacc.2012.12.046
Brewster S, Bartholomew J, Holt RIG, Price H. Non-attendance at diabetes outpatient appointments: a systematic review. Diabet Med. 2020;37(9):1427-1442. https://doi.org/10.1111/dme.14241
Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment non-compliance on mortality in people with type 1 diabetes. J Diabetes Complications. 2013;27(3):219-223. https://doi.org/10.1016/j.jdiacomp.2012.10.006
Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057-1065. https://doi.org/10.1136/thoraxjnl-2013-204282